PET Biodistribution Study of 68Ga-PSMA-11 and 68Ga-FAPI-46
Status:
Not yet recruiting
Trial end date:
2031-10-01
Target enrollment:
Participant gender:
Summary
The tumor stroma supports tumor growth, promotes tumor aggressiveness and metastatic
potential. Stroma targeting approaches have become an attractive goal in research and
industry. Braking the tumor stroma barrier may make tumor cells more accessible for
pharmacologic, immunologic, radioactive or cell-based therapies.